MRS 4062 triethylammonium saltSelective P2Y4 receptor agonist CAS# 1309871-50-8 |
2D Structure
- MTEP hydrochloride
Catalog No.:BCC1780
CAS No.:1186195-60-7
- mGlu2 agonist
Catalog No.:BCC1745
CAS No.:1311385-32-6
- LY341495
Catalog No.:BCC1724
CAS No.:201943-63-7
- CPPHA
Catalog No.:BCC1501
CAS No.:693288-97-0
- Dipraglurant
Catalog No.:BCC1531
CAS No.:872363-17-2
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1309871-50-8 | SDF | Download SDF |
PubChem ID | 90488925 | Appearance | Powder |
Formula | C42H86N7O15P3 | M.Wt | 1022.09 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in water (supplied pre-dissolved at a concentration of 10mM) | ||
Chemical Name | [[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[2-oxo-4-(3-phenylpropoxyamino)pyrimidin-1-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate;triethylazanium | ||
SMILES | CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.C1=CC=C(C=C1)CCCONC2=NC(=O)N(C=C2)C3C(C(C(O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O | ||
Standard InChIKey | ZCDZFMKRHPANNI-IHQKQWLFSA-N | ||
Standard InChI | InChI=1S/C18H26N3O15P3.4C6H15N/c22-15-13(11-33-38(28,29)36-39(30,31)35-37(25,26)27)34-17(16(15)23)21-9-8-14(19-18(21)24)20-32-10-4-7-12-5-2-1-3-6-12;4*1-4-7(5-2)6-3/h1-3,5-6,8-9,13,15-17,22-23H,4,7,10-11H2,(H,28,29)(H,30,31)(H,19,20,24)(H2,25,26,27);4*4-6H2,1-3H3/t13-,15-,16-,17-;;;;/m1..../s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective P2Y4 receptor agonist (EC50 values are 23, 640, and 740 nM for hP2Y4, hP2Y2 and hP2Y6 respectively). |
MRS 4062 triethylammonium salt Dilution Calculator
MRS 4062 triethylammonium salt Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.9784 mL | 4.8919 mL | 9.7839 mL | 19.5677 mL | 24.4597 mL |
5 mM | 0.1957 mL | 0.9784 mL | 1.9568 mL | 3.9135 mL | 4.8919 mL |
10 mM | 0.0978 mL | 0.4892 mL | 0.9784 mL | 1.9568 mL | 2.446 mL |
50 mM | 0.0196 mL | 0.0978 mL | 0.1957 mL | 0.3914 mL | 0.4892 mL |
100 mM | 0.0098 mL | 0.0489 mL | 0.0978 mL | 0.1957 mL | 0.2446 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Sephin1
Catalog No.:BCC3980
CAS No.:13098-73-2
- (±)-CPSI 1306
Catalog No.:BCC6161
CAS No.:1309793-47-2
- H 89 2HCl
Catalog No.:BCC4997
CAS No.:130964-39-5
- Marumoside A
Catalog No.:BCN7702
CAS No.:1309604-34-9
- Wittifuran X
Catalog No.:BCN4794
CAS No.:1309478-07-6
- K145
Catalog No.:BCC4305
CAS No.:1309444-75-4
- GPR40 Activator 1
Catalog No.:BCC4125
CAS No.:1309435-60-6
- Cerberic acid B
Catalog No.:BCN4715
CAS No.:1309362-77-3
- CX-4945 sodium salt
Catalog No.:BCC5586
CAS No.:1309357-15-0
- Entacapone
Catalog No.:BCC2217
CAS No.:130929-57-6
- 7-O-Acetylneocaesalpin N
Catalog No.:BCN7332
CAS No.:1309079-08-0
- N4-Benzoylcytidine
Catalog No.:BCC9072
CAS No.:13089-48-0
- 15-Methoxymkapwanin
Catalog No.:BCN6498
CAS No.:1309920-99-7
- VU 0360172 hydrochloride
Catalog No.:BCC6141
CAS No.:1309976-62-2
- alpha-Yohimbine
Catalog No.:BCN6166
CAS No.:131-03-3
- Dimethyl phthalate
Catalog No.:BCN6167
CAS No.:131-11-3
- Pimpinellin
Catalog No.:BCN6168
CAS No.:131-12-4
- N-Acetylneuraminic acid
Catalog No.:BCN2204
CAS No.:131-48-6
- Oxybenzone
Catalog No.:BCC5445
CAS No.:131-57-7
- Meptyldinocap
Catalog No.:BCC5468
CAS No.:131-72-6
- 8-Epiloganic acid
Catalog No.:BCC8956
CAS No.:82509-41-9
- Boldenone undecylenate
Catalog No.:BCC8896
CAS No.:13103-34-9
- GNF179 Metabolite
Catalog No.:BCC5176
CAS No.:1310455-86-7
- NB-598
Catalog No.:BCC1786
CAS No.:131060-14-5
Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate delta-ester modifications as selective agonists of the P2Y(4) receptor.[Pubmed:21528910]
J Med Chem. 2011 Jun 23;54(12):4018-33.
P2Y(2) and P2Y(4) receptors are G protein-coupled receptors, activated by UTP and dinucleoside tetraphosphates, which are difficult to distinguish pharmacologically for lack of potent and selective ligands. We structurally varied phosphate and uracil moieties in analogues of pyrimidine nucleoside 5'-triphosphates and 5'-tetraphosphate esters. P2Y(4) receptor potency in phospholipase C stimulation in transfected 1321N1 human astrocytoma cells was enhanced in N(4)-alkyloxycytidine derivatives. OH groups on a terminal delta-glucose phosphoester of uridine 5'-tetraphosphate were inverted or substituted with H or F to probe H-bonding effects. N(4)-(Phenylpropoxy)-CTP 16 (MRS4062), Up(4)-[1]3'-deoxy-3'-fluoroglucose 34 (MRS2927), and N(4)-(phenylethoxy)-CTP 15 exhibit >/=10-fold selectivity for human P2Y(4) over P2Y(2) and P2Y(6) receptors (EC(50) values 23, 62, and 73 nM, respectively). delta-3-Chlorophenyl phosphoester 21 of Up(4) activated P2Y(2) but not P2Y(4) receptor. Selected nucleotides tested for chemical and enzymatic stability were much more stable than UTP. Agonist docking at CXCR4-based P2Y(2) and P2Y(4) receptor models indicated greater steric tolerance of N(4)-phenylpropoxy group at P2Y(4). Thus, distal structural changes modulate potency, selectivity, and stability of extended uridine tetraphosphate derivatives, and we report the first P2Y(4) receptor-selective agonists.